iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Vivo Bio Tech standalone net profit declines 57.14% in the September 2022 quarter

16 Nov 2022 , 02:03 PM

Net profit of Vivo Bio Tech declined 57.14% to Rs 0.12 crore in the quarter ended September 2022 as against Rs 0.28 crore during the previous quarter ended September 2021. Sales rose 23.30% to Rs 12.54 crore in the quarter ended September 2022 as against Rs 10.17 crore during the previous quarter ended September 2021.

Particulars Quarter Ended
? Sep. 2022 Sep. 2021 % Var.
Sales 12.54 10.17 23
OPM % 37.24 37.86
PBDT 2.89 2.81 3
PBT 0.52 1.07 -51
NP 0.12 0.28 -57

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.